These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28804146)

  • 1. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights January - March 2017.
    Klafehn CW; Williams A
    Hosp Pharm; 2017 May; 52(5):327-329. PubMed ID: 28804146
    [No Abstract]   [Full Text] [Related]  

  • 2. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights.
    Rose B
    Hosp Pharm; 2016 Jun; 51(6):491-2. PubMed ID: 27354752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2017.
    Office of Health and Constituent Affairs U.S. Food and Drug Administration
    Am J Health Syst Pharm; 2017 Jun; 74(11):770. PubMed ID: 28546297
    [No Abstract]   [Full Text] [Related]  

  • 4. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2018.
    Am J Health Syst Pharm; 2018 Jun; 75(11):738. PubMed ID: 29802107
    [No Abstract]   [Full Text] [Related]  

  • 5. Summaries of Safety Labeling Changes Approved By FDA: Boxed Warnings Highlights January-March 2018.
    Hosp Pharm; 2018 Jul; 53(4):223-224. PubMed ID: 30038438
    [No Abstract]   [Full Text] [Related]  

  • 6. Summaries of Safety Labeling Changes Approved By FDA—Boxed Warnings Highlights January-March 2015.
    Rubio T
    Am J Health Syst Pharm; 2015 Jun; 72(11):900, 902, 904. PubMed ID: 25987678
    [No Abstract]   [Full Text] [Related]  

  • 7. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2019.
    Am J Health Syst Pharm; 2019 Jun; 76(13):932. PubMed ID: 31361886
    [No Abstract]   [Full Text] [Related]  

  • 8. Summaries of safety labeling changes approved by FDA-boxed warnings highlights January-March 2016.
    Am J Health Syst Pharm; 2016 Jun; 73(11):739-40. PubMed ID: 27208054
    [No Abstract]   [Full Text] [Related]  

  • 9. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2018.
    Am J Health Syst Pharm; 2018 Jun; 75(11):e339-e341. PubMed ID: 29802116
    [No Abstract]   [Full Text] [Related]  

  • 10. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March, 2020.
    Am J Health Syst Pharm; 2020 Jun; 77(13):e9-e10. PubMed ID: 32573719
    [No Abstract]   [Full Text] [Related]  

  • 11. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March, 2020.
    Am J Health Syst Pharm; 2020 Jun; 77(13):1003-1004. PubMed ID: 32573718
    [No Abstract]   [Full Text] [Related]  

  • 12. Summaries of safety labeling changes approved by FDA-boxed warnings highlights January-March 2016.
    Am J Health Syst Pharm; 2016 Jun; 73(11):e375-7. PubMed ID: 27208062
    [No Abstract]   [Full Text] [Related]  

  • 13. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights July-September 2016.
    Rubio T
    Hosp Pharm; 2016 Dec; 51(11):941-943. PubMed ID: 28057955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights October - December 2016.
    Rose BJ
    Hosp Pharm; 2017 Feb; 52(2):153-154. PubMed ID: 28321144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2017.
    Office of Health and Constituent Affairs, U.S. Food and Drug Administration
    Am J Health Syst Pharm; 2017 Jun; 74(11):e292-e294. PubMed ID: 28546306
    [No Abstract]   [Full Text] [Related]  

  • 16. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March, 2021.
    Am J Health Syst Pharm; 2021 Jun; 78(13):1164-1165. PubMed ID: 33998647
    [No Abstract]   [Full Text] [Related]  

  • 17. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March, 2021.
    Am J Health Syst Pharm; 2021 Jun; 78(13):e6-e8. PubMed ID: 34043003
    [No Abstract]   [Full Text] [Related]  

  • 18. Summaries of safety labeling changes approved by FDA-boxed warnings highlights March-June 2016.
    Office of Health & Constituent Affairs U.S. Food and Drug Administration
    Am J Health Syst Pharm; 2016 Sep; 73(17):e573-8. PubMed ID: 27543581
    [No Abstract]   [Full Text] [Related]  

  • 19. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2022.
    Am J Health Syst Pharm; 2022 Jun; ():. PubMed ID: 35661192
    [No Abstract]   [Full Text] [Related]  

  • 20. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2022.
    Am J Health Syst Pharm; 2022 Jun; ():. PubMed ID: 35661193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.